Aarti Drugs Share Price
425.85+0.00 (+1.93%)
-13.16% past 1 Year
News
Aarti Drugs appoints new chairman and managing director from October 2026
Equity
AARTIDRUGS
Aarti Drugs appoints Adhish P. Patil as Managing Director for five years
Equity
AARTIDRUGS
Aarti Drugs reports strong Q1 EBITDA growth and margin expansion YoY
Equity
AARTIDRUGS
Aarti Drugs reports higher Q1 revenue on year, details not disclosed
Equity
AARTIDRUGS
Aarti Drugs Q1 FY27 consolidated net profit declines marginally year on year
Equity
AARTIDRUGS
Aarti Drugs ordered to shut Gujarat Saykha Amines plant by GPCB directive
Equity
AARTIDRUGS
Aarti Drugs informs about newspaper publication
Equity
AARTIDRUGS
Aarti Drugs Q4 EBITDA declines year-on-year with narrower operating margins reported
Equity
AARTIDRUGS
Aarti Drugs Q4 FY earnings show revenue growth but net profit decline YoY
Equity
AARTIDRUGS
Aarti Drugs reports Profit after tax of 44.96 Crores, in the March 2026 quarter
Equity
AARTIDRUGS
Aarti Drugs informs about newspaper publication
Equity
AARTIDRUGS
Aarti Drugs gets nod to make investment in Pinnacle Life Science
Equity
AARTIDRUGS
Aarti Drugs informs about investment in equity shares of WOS
Equity
AARTIDRUGS
Aarti Drugs rises as its arm incorporates overseas wholly owned subsidiary
Equity
AARTIDRUGS
Aarti Drugs’ arm incorporates overseas wholly owned subsidiary
Equity
AARTIDRUGS
Aarti Drugs - Quaterly Results
Equity
AARTIDRUGS
Aarti Drugs Declares Interim Dividend of Rs 2 Per Share for FY2025-26
Equity
AARTIDRUGS
Aarti Drugs Q3 FY26 EBITDA Declines YoY Amid Margin Compression
Equity
AARTIDRUGS
Aarti Drugs Q3FY25 Earnings: Net Profit Up 1.1% YoY to Rs 37 Crore, Revenue Down 8.1% to Rs 557 Crore.
Equity
AARTIDRUGS
Aarti Drugs reports Profit after tax of 33.84 Crores, in the December 2025 quarter
Equity
AARTIDRUGS